RUJUTA SAKSENA, MD
Hematology & Oncology Physician · SUMMIT, NJ
Individual Active NPI 1851522197
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 330 | 22,726 | $2,053,745 | $575,519 | $454,836 |
| 2023 | 380 | 63,473 | $3,597,767 | $1,101,264 | $875,139 |
| 2022 | 363 | 17,827 | $837,838 | $354,286 | $273,959 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,800 | $19 | $15 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 490 | $8 | $8 |
| 36415 | Insertion of needle into vein for collection of blood sample | 411 | $9 | $9 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 396 | $0 | $0 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 382 | $134 | $97 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 105 | $30 | $24 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 100 | $81 | $64 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 90 | $17 | $13 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 63 | $67 | $52 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $77 | $59 |
| 96372 | Injection of drug or substance under skin or into muscle | 62 | $15 | $12 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 55 | $177 | $141 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | MA89716 | NJ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in New Jersey
- NPI 1922090802
- NPI 1295028405
- NPI 1972610731
- NPI 1568454080
- NPI 1679930994
- NPI 1184787723
- NPI 1619059987
- NPI 1518165919
See all Hematology & Oncology Physician providers in New Jersey →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.